ClinicalTrials.gg
CompletedNCT02002728Updated Dec 9, 2013

Comparison of Early Caries Detection in Children Utilizing an Electrical Conductance Device and the Gold Standard of Visual-tactile Technique.

An observational study in Dental Caries in Children, sponsored by Ortek Therapeutics, Inc.. Completed at 1 site in Venezuela. Open to participants aged 6 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-12-09.

Sponsored by Ortek Therapeutics, Inc. · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
200
Ages
6 Years to 9 Years
Sex
All
01

Study summary

The purpose of this study is to evaluate a methodology for detecting early forming cavities in children that is more accurate and reliable than the gold standard used by dentists around the world. The new method uses an electrical current device to detect early enamel mineral loss before it can develop into a cavity. The manual gold standard is for a dentist to probe the surfaces of the teeth with a fine pick, searching for areas of defect.

02

Conditions studied

  • Dental Caries in Children
03

In context

Lead sponsor

This is the only study on the registry with Ortek Therapeutics, Inc. as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Children ages 6 - 9 years.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Children whose parents authorize participation by signing a consent form. Children who attend public school only. Children in good health. Children between 6 and 9 years of age. Children with all first permanent molars erupted. All permanent first molars must not have any signs of cavitation but only one molar can have some mineral loss(e.g. white spots).

Children must show some caries in the primary molars as a sign of caries susceptibility.

-

Exclusion criteria

Exclusion Criteria:

Children of parents or a guardian who do not agree to participate in the study. Children registered in private schools. Children not in good health. Children undergoing antimicrobial or antibiotic treatment. Children outside the range of age selected for the study. Children with one or more first permanent molars unerupted. Children with any cavitation in the occlusal surface of any first permanent molar.

Children who do not have a sign of dental caries in the primary molars as a sign of caries susceptibility.

Children who do not allow themselves to be examined.

-

05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
200 participants (actual)
Target follow-up
14 Months
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. To compare the detection of occlusal caries lesions in the first permanent molars of Venezuelan children by electrical conductance and visual-tactile means.

    Time frame: 14 months from baseline assessment

07

Study locations

1 site
  • Universidad Central de Venezuela
    Caracas, Venezuela 1050, Venezuela
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 9, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02002728
Lead sponsor
Ortek Therapeutics, Inc.
Responsible party
Sponsor
First posted
Dec 6, 2013
Start date
Nov 2006
Primary completion
Apr 2009
Completion
Apr 2009
Last update
Dec 9, 2013

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion